NCT07745725 — Systemic Sclerosis (SSc) trial site landscape

Public-registry site landscape for NCT07745725, “A Phase II Study of TollB-001 Tablets in Systemic Sclerosis”, a Systemic Sclerosis (SSc) study sponsored by Toll Biotech Co. Ltd. (Beijing). All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT07745725 (registry record)
Study title	A Phase II Study of TollB-001 Tablets in Systemic Sclerosis
Official title	A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of TollB-001 Tablets in Patients With Systemic Sclerosis
Sponsor	Toll Biotech Co. Ltd. (Beijing)
Condition(s)	Systemic Sclerosis (SSc)
Phase	PHASE2
Listed sites	2
Site countries	China

Patient-friendly overview of this study: eichor.com/study/NCT07745725.

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT07745725 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →